SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-23-113868
Filing Date
2023-04-25
Accepted
2023-04-25 06:07:35
Documents
5
Group Members
CONCENTRA BIOSCIENCES, LLCTANG CAPITAL MANAGEMENT, LLCTANG CAPITAL PARTNERS, LP

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d491253dsctota.htm SC TO-T/A 47021
2 EX-99.(A)(1)(E) d491253dex99a1e.htm EX-99.(A)(1)(E) 41235
3 EX-99.(A)(1)(F) d491253dex99a1f.htm EX-99.(A)(1)(F) 433630
4 GRAPHIC g491253g0425013800722.jpg GRAPHIC 3779
5 GRAPHIC g491253g0425013800831.jpg GRAPHIC 3431
  Complete submission text file 0001193125-23-113868.txt   533779
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Subject) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-89831 | Film No.: 23841549
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 (858) 200-3830
Concentra Merger Sub, Inc. (Filed by) CIK: 0001972123 (see all company filings)

IRS No.: 923233597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A